Studies have shown that phytosterols are effective to lower serum CT and LDL-C levels without affecting HDL-C but few data are available in children. Aim of this study is evaluate the effect of plant sterols intake in dyslipemic children.Methods: 33 patients (18 FH; 15 IperLp(a)-FCHL, 6-18 yrs) underwent phytosterols dietary supplementation (1,6-2 g/die) to check any lipoprotein profile and serum sterols change. The latter were tested using gas chromatography-mass spectrometry with selective ion monitoring as previously reported; serum lipoprotein profile were checked by standard methods.The disorder diagnosis was based on familial background, LDL-R gene mutation detection, lipoprotein profile.Study design: Patients were submitted to lipid evaluation in basal condition on step I diet and two months after phytosterols intake.Results: 9/18 FH patients and 9/15 dyslipemic children resulted responders.CT and LDL-C reduction was 14,2 and 18,8 % in FH; while other dyslipemias showed a more relevant decrease of 16,7 and 27,5 % respectively. The lathosterol, desmosterol synthesis and campesterol, sitosterol, cholestanol absorbtion markers detection suggest a synthesis reduction and an absorption increase. An inverse correlation between lathosterol and campesterol levels is presently demonstrated:r=-0,22.Conclusion: A decrease of all biochemical markers is detected in 54% of all tested patients (50% in FH and 60% in the other dyslipemias ). Results are in agreement with preliminary reported data and suggest the relevance of monitoring patients in order to assess the responsiveness to phytosterols association to diet.

Phytosterols Therapy in Children.

GUARDAMAGNA, Ornella;
2006-01-01

Abstract

Studies have shown that phytosterols are effective to lower serum CT and LDL-C levels without affecting HDL-C but few data are available in children. Aim of this study is evaluate the effect of plant sterols intake in dyslipemic children.Methods: 33 patients (18 FH; 15 IperLp(a)-FCHL, 6-18 yrs) underwent phytosterols dietary supplementation (1,6-2 g/die) to check any lipoprotein profile and serum sterols change. The latter were tested using gas chromatography-mass spectrometry with selective ion monitoring as previously reported; serum lipoprotein profile were checked by standard methods.The disorder diagnosis was based on familial background, LDL-R gene mutation detection, lipoprotein profile.Study design: Patients were submitted to lipid evaluation in basal condition on step I diet and two months after phytosterols intake.Results: 9/18 FH patients and 9/15 dyslipemic children resulted responders.CT and LDL-C reduction was 14,2 and 18,8 % in FH; while other dyslipemias showed a more relevant decrease of 16,7 and 27,5 % respectively. The lathosterol, desmosterol synthesis and campesterol, sitosterol, cholestanol absorbtion markers detection suggest a synthesis reduction and an absorption increase. An inverse correlation between lathosterol and campesterol levels is presently demonstrated:r=-0,22.Conclusion: A decrease of all biochemical markers is detected in 54% of all tested patients (50% in FH and 60% in the other dyslipemias ). Results are in agreement with preliminary reported data and suggest the relevance of monitoring patients in order to assess the responsiveness to phytosterols association to diet.
2006
XX Congresso Nazionale SISA
Bologna
16-19 novembre 2006
16 (1)
S11
S11
terapia ipocolesterolemizzante; fitosteroli; assorbimento intestinale
Giachino P; Mannucci L; Guardamagna O; Bertucci P; Fabbri C; Cortese C
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/122455
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact